arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

X4 Pharmaceuticals, Inc

XFOR

$4.62 ▲ +0.46 (+11.04%) at close

11 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

X4 Pharmaceuticals, Inc faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $195.4M

Dividend Yield —

Revenue Growth 1273.2%

Op. Margin -247.4%

ROIC -33.3% ↗

FCF / Share $-2.02 ↗

Trailing P/E —

Price / Book 2.3x

FCF Yield —

Debt / Equity 0.40

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$35.11M

↑ +1273.2% —

Net Income Profit after all expenses

$-79.20M

↓ -111.5% —

FCF / Share Free cash flow per share

$-2.02

↑ +89.7% —

Long-Term Debt Long-term obligations

$75.00M

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↑

Financial Health →

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	1273.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+15815%)	—	—	—	N/M	—	—	—	—	—	—
EPS Growth YoY (%)	67.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	66.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	61.9% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-111.5% Weak ↓ Weak Declining Year-over-year change in net income	63.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-7.8% Weak ↑ Weak Improving Year-over-year change in net income	-5.8% Weak ↑ Weak Improving Year-over-year change in net income	-42.8% Weak ↓ Weak Declining Year-over-year change in net income	-17.7% Weak ↑ Weak Improving Year-over-year change in net income	-58.7% Weak ↓ Weak Declining Year-over-year change in net income	1.7% Caution Caution Year-over-year change in net income	-47.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	89.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-20.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	55.3% Excellent Excellent Year-over-year change in free cash flow	55.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	63.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	-247.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1750%)	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	-225.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1980%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-243.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.08x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	3.50x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-33.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-101.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-87.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	34.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-48.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	34.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-29.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-56.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-292.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-44.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-42.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-383%)	-169.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1227%)	-198.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1420%)	-126.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-945%)	-137.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1018%)	-85.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-669%)	-40.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-372%)	43.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+188%)	-57.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-485%)	40.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+171%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Debt to Equity (x)	0.40x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-33%)	3.39x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+464%)	1.08x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+79%)	0.44x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-27%)	0.50x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-16%)	0.45x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-26%)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	-0.13x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-122%)	—	—	—
Interest Coverage (x)	-10.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.69x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23.35x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-21.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.27x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-40.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17.38x Weak Weak Operating income divided by interest expense Optimal: > 5x	-9.68x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-142.05M	$19.30M	$-44.22M	$-89.22M	$-49.29M	$-46.21M	$-106.18M	$1.87M	$-76.79M	—	—
Debt / EBITDA (x)	-0.88x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.51x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.37x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.38x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.55x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.39x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.35x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$0.83	$0.38	$0.00	$0.00	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.87	$-5.71	$-17.12	$-45.65	$-119.82	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.02	$-19.60	$-16.31	$-36.45	$-82.69	—	—	—	—	—	—
Book Value per Share (USD)	$2.05	$3.89	$9.16	$18.28	$68.77	$134.07	$240.59	$-6.58K	$739.85	—	—
Tangible Book Value per Share (USD)	$1.86	$0.84	$6.05	$13.99	$50.24	$84.15	$190.12	$-6.58K	$739.85	—	—
Basic Weighted Avg Shares (shares)	42.29M	6.70M	5.92M	2.12M	857,442	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$235.82M	$79.30M	$99.21M	$106.35M	$73.86M	$71.36M	$119.83M	$1.43M	$68.85M	—	—
LT Debt (USD)	$75.00M	$75.00M	$55.00M	$32.50M	$32.50M	$32.50M	$20.00M	$10.00M	—	—	—
Total Equity (USD)	$186.29M	$22.15M	$51.10M	$74.05M	$64.41M	$72.80M	$129.22M	$-77.09M	$58.71M	$-56.56M	$-34.32M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$35.11M	$2.56M	$0.00	$0.00	$0.00	$3.00M	$0.00	—	—	—	—
Depreciation Expense (USD)	$1.28M	$796.00K	$419.00K	$513.00K	$499.00K	$351.00K	$103.00K	$103.00K	$195.00K	$285.00K	—
Net Income, GAAP (USD)	$-79.20M	$-37.45M	$-101.17M	$-93.87M	$-88.70M	$-62.13M	$-52.81M	$-33.28M	$-33.88M	$-22.98M	—
Operating Cash Flow (USD)	$-85.62M	$-130.90M	$-96.51M	$-77.10M	$-70.91M	$-58.82M	$-48.05M	$-25.42M	$-27.87M	$-21.64M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 39 quarters

X4 Pharmaceuticals, Inc

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare XFOR with peers